Polysorbates 20 and 80 Used in the Formulation of Protein Biotherapeutics:  Structure and Degradation Pathways - Journal of Pharmaceutical Sciences

Polysorbates 20 and 80 Used in the Formulation of Protein Biotherapeutics: Structure and Degradation Pathways - Journal of Pharmaceutical Sciences

4.9
(716)
Write Review
More
$ 31.00
Add to Cart
In stock
Description

PDF) Physical and biophysical effects of polysorbate 20 and 80 on darbepoetin alfa

Structural and biochemical characterization of a novel thermophilic Coh01147 protease

Structural and biochemical characterization of a novel thermophilic Coh01147 protease

Applied Sciences, Free Full-Text

Main degradation pathways of polysorbate 80.

Nanomaterials in Alzheimer's disease treatment: a comprehensive review

Synthesis and Characterization of Lyophilized Chitosan-Based Hydrogels Cross-Linked with Benzaldehyde for Controlled Drug Release. - Document - Gale Academic OneFile

Ocular delivery of proteins and peptides: Challenges and novel formulation approaches. - Abstract - Europe PMC

Formulation mitigations for particle formation induced by enzymatic hydrolysis of polysorbate 20 in protein-based drug products: insights from a full-factorial longitudinal study, AAPS Open